en_US EN
en_US EN ro_RO RO sr_RS SR pt_PT PT mk_MK MK
References – PAGE, Module 1
  1. UNAIDS. Health, rights and drugs: Harm reduction, decriminalization and zero discrimination for people who use drugs. Geneva: UNAIDS; 2019. Available from: https://www.unaids.org/en/resources/documents/2019/JC2954_UNAIDS_drugs_report_2019
  2. World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: WHO; 2004.
    Available from:     https://www.unodc.org/documents/hiv-aids/EFA%20effectiveness%20sterile%20needle.pdf
  3. UNAIDS. Do no harm: Health, human rights and people who use drugs. Geneva: UNAIDS; 2016. Available from: https://www.unaids.org/en/resources/documents/2016/do-no-harm
  4. Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Palmateer N, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–248. doi:10.1093/ije/dyt243.
    Available From:     https://pubmed.ncbi.nlm.nih.gov/24374889/
  5. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. 2nd ed. Geneva: WHO; 2016. Available From: https://iris.who.int/server/api/core/bitstreams/6a1197da-bddb-4bfc-8f91-d84e302f8b37/content
  6. Salisbury-Afshar E, Livingston CJ, Bluthenthal RN. How should harm reduction be included in care continua for patients with opioid use disorder? AMA J Ethics. 2024;26(7):E562–E571. Available from: https://journalofethics.ama-assn.org/article/how-should-harm-reduction-e-included-care-continua-patients-opioid-use-disorder/2024-07
  7. United Nations Office on Drugs and Crime, World Health Organization, UNAIDS. Principles of Drug Dependence Treatment. Vienna: UNODC; 2010. Available from: https://www.unodc.org/documents/drug-treatment/UNODC-WHO-Principles-of-Drug-Dependence-Treatment-March08.pdf
  8. Harm Reduction International. The Global State of Harm Reduction 2022. London: HRI; 2022. Available from: https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2022/
  9. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2021: Trends and Developments. Lisbon: EMCDDA; 2021. Available from: https://www.euda.europa.eu/edr2021_en
  10. Global Commission on Drug Policy. Taking control: Pathways to drug policies that work. Geneva: GCDP; 2014. Available from: https://globalcommissionondrugs.org/gcdp-reports/taking-control-pathways-to-drug-policies-that-work/
  11. Des Jarlais DC, Friedman SR, Hagan H. The history of needle-exchange programs in the United States. Addiction. 1996;91(9):1291–1298.Available from: https://pubmed.ncbi.nlm.nih.gov/9221326/
  12. Stimson GV. AIDS and HIV: the challenge for British drug policy. BMJ. 1987;294(6571):1089–1090. Availale from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/aids-and-hiv-challenge-british-drug-services
  13. Hedrich D. European report on drug consumption rooms. Lisbon: EMCDDA; 2004. Available from: https://www.euda.europa.eu/publications/technical-reports/european-report-drug-consumption-rooms-2004_en
  14. Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone in the United States. MMWR Morb Mortal Wkly Rep. 2015;64(23):631–635. Available from: https://pubmed.ncbi.nlm.nih.gov/26086633/
  15. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva: WHO; 2014. Available from: https://iris.who.int/server/api/core/bitstreams/6a1197da-bddb-4bfc-8f91-d84e302f8b37/content
  16. Marshall BDL, Milloy MJ, Wood E, Montaner JSG, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet.2011;377(9775):1429–1437. Available from: https://pubmed.ncbi.nlm.nih.gov/21497898/
  17. Vancouver Coastal Health. Supervised injection services: Insite user statistics 2003–2019. Vancouver: VCH; 2019. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6879115/
  18. World Health Organization, UNODC, UNAIDS. Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for people who inject drugs. Geneva: WHO; 2012. Available from: https://www.who.int/publications/i/item/978924150437
  19. Hughes C, Stevens A. What can we learn from the Portuguese decriminalization of illicit drugs? Br J Criminol.2010;50(6):999–1022. Available from: https://www.researchgate.net/publication/249284847_What_Can_We_Learn_From_The_Portuguese_Decriminalization_of_Illicit_Drugs
  20. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Liverpool: LJMU Centre for Public Health; 2006.Available from: https://www.nice.org.uk/guidance/ph52/evidence/a-review-of-the-effectiveness-and-costeffectiveness-of-needle-and-syringe-programmes-for-injecting-drug-users-pdf-11315724595
  21. Izenberg JM, Bachireddy C, Soule M, Kiriazova T, Dvoryak S, Altice FL. High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes. Drug Alcohol Depend. 2013 Nov 1;133(1):154-60. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3786010/
  22. Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326:959–960. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC153851/
  23. Council of the European Union. EU Drugs Strategy 2021–2025. Brussels: Council of the EU; 2020. Available from: https://www.consilium.europa.eu/media/49194/eu-drugs-strategy-booklet.pdf
  24. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2023: Trends and Developments. Lisbon: EMCDDA; 2023.Available from: https://www.euda.europa.eu/publications/european-drug-report/2023_en
  25. European Monitoring Centre for Drugs and Drug Addiction. Portugal: Country Drug Report 2023. Lisbon: EMCDDA; 2023.Available from: https://www.euda.europa.eu/partners/portugal_en
  26. World Health Organization. Community management of opioid overdose. Geneva: WHO; 2014. Available From:https://www.who.int/publications/i/item/9789241548816
  27. European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances in Europe: An update from the EU Early Warning System. Lisbon: EMCDDA; 2019.  Available from: https://www.euda.europa.eu/system/files/publications/3353/TD0416736ENN.pdf